{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:56:39Z","timestamp":1773230199577,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.vaccine.2004.08.051","type":"journal-article","created":{"date-parts":[[2004,11,8]],"date-time":"2004-11-08T18:47:18Z","timestamp":1099939638000},"page":"1739-1745","source":"Crossref","is-referenced-by-count":64,"title":["Pneumococcal pneumonia in the UK\u2014how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV)"],"prefix":"10.1016","volume":"23","author":[{"given":"E.D.G.","family":"McIntosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Willingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.08.051_bib1","unstructured":"Donaldson L, Mullally S, Smith J. Adult immunisation. From the Chief Medical Officer, the Chief Nursing Officer and the Chief Pharmaceutical Officer. 8 August 2003 (http:\/\/www.doh.gov.uk\/cmo\/letters\/cmo0306.htm)."},{"key":"10.1016\/j.vaccine.2004.08.051_bib2","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/S0264-410X(03)00031-8","article-title":"The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine","volume":"21","author":"McIntosh","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.08.051_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/oxfordjournals.aje.a121310","article-title":"Herd immunity: basic concept and relevance to public health immunization practices","volume":"94","author":"Fox","year":"1971","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2004.08.051_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.epirev.a036121","article-title":"Herd immunity: history, theory, practice","volume":"15","author":"Fine","year":"1993","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2004.08.051_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2004.08.051_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.inf.0000069760.65826.f2","article-title":"Vaccination of day-care attendees reduces carriage of Streptococcus pneumoniae among their younger siblings","volume":"22","author":"Givon-Lavi","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2004.08.051_bib7","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1007\/s00431-002-1064-z","article-title":"Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California","volume":"161","author":"Black","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2004.08.051_bib8","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2004.08.051_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0272989X02239651","article-title":"Economic evaluation of vaccination programs: the impact of herd-immunity","volume":"23","author":"Brisson","year":"2003","journal-title":"Med Decis Making"},{"key":"10.1016\/j.vaccine.2004.08.051_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia","volume":"21","author":"Black","year":"2002","journal-title":"Paediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.08.051_bib11","unstructured":"Hospital Episode Statistics. Department of Health, Kate Byram Ref. ET0095, dated 2 July 2003."},{"key":"10.1016\/j.vaccine.2004.08.051_bib12","unstructured":"http:\/\/www.statistics.gov.uk\/downloads\/theme_health\/DH2_26_1999\/DH2_26.pdf (accessed 29 June 2003)."},{"key":"10.1016\/j.vaccine.2004.08.051_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/thorax.55.2.133","article-title":"Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study","volume":"55","author":"Lorente","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2004.08.051_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/JCM.37.3.709-714.1999","article-title":"Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia","volume":"37","author":"Garc\u00eda","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2004.08.051_bib15","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JCM.39.10.3495-3498.2001","article-title":"Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia","volume":"39","author":"Murdoch","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2004.08.051_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/JCM.41.1.63-66.2003","article-title":"Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia","volume":"41","author":"Murdoch","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2004.08.051_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.08.051_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/00006454-200111000-00004","article-title":"Pneumococcal carriage in children during their first two years: important role of family exposure","volume":"20","author":"Leino","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.08.051_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/0-306-46831-X_6","article-title":"Initial steps in Streptococcus pneumoniae interaction with and pathogenicity to the host","volume":"479","author":"Shani-Sekler","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2004.08.051_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/bmj.290.6467.505","article-title":"Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital","volume":"290","author":"Gransden","year":"1985","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1016\/j.vaccine.2004.08.051_bib21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.270.15.1826","article-title":"Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2004.08.051_bib22","unstructured":"http:\/\/www.dh.gov.uk\/assetRoot\/04\/06\/98\/00\/04069800.pdf."},{"key":"10.1016\/j.vaccine.2004.08.051_bib23","unstructured":"Centers for Disease Control and Prevention, National Immunization Program, Record of the Advisory Committee on Immunization Practices, 15\u201316 October, 2003 (http:\/\/www.cdc.gov\/nip\/ACIP\/minutes.htm)."},{"key":"10.1016\/j.vaccine.2004.08.051_bib24","series-title":"Effect of pneumococcal conjugate vaccine on invasive disease in the US. The 4th International Symposium on Pneumococci and Pneumococcal Disease (ISPPD-4), 9\u201313 May","author":"Whitney","year":"2004"},{"issue":"March, no. 1","key":"10.1016\/j.vaccine.2004.08.051_bib25","article-title":"Pneumococcal bacteraemia and meningitis in England and Wales 1993\u20131995","volume":"1","author":"Laurichesse","year":"1998","journal-title":"Commun Dis Public Health"},{"key":"10.1016\/j.vaccine.2004.08.051_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0022-3476(99)70438-5","article-title":"Infant Hib vaccination and herd immunity","volume":"134","author":"Rushdy","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2004.08.051_bib27","series-title":"Vaccines","first-page":"553","article-title":"Pneumococcal vaccine","author":"Fedson","year":"1999"},{"key":"10.1016\/j.vaccine.2004.08.051_bib28","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00006454-200110000-00008","article-title":"Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees","volume":"20","author":"Dagan","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.08.051_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422653","article-title":"Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine","volume":"39","author":"Talbot","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2004.08.051_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2004.08.051_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumocccal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2004.08.051_bib32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1086\/381547","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings","volume":"38","author":"Regev-Yochay","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2004.08.051_bib33","unstructured":"Chief Medical Officer (www.doh.gov.uk\/cmo\/cmo0201)."},{"key":"10.1016\/j.vaccine.2004.08.051_bib34","unstructured":"Medical Devices Agency (MDA) DA 2002 (09) August 2002."},{"key":"10.1016\/j.vaccine.2004.08.051_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/adc.86.6.403","article-title":"Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine?","volume":"86","author":"McIntosh","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2004.08.051_bib36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.273.11.859","article-title":"Risk factors for primary invasive pneumococcal disease among children in Finland","volume":"273","author":"Takala","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2004.08.051_bib37","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1542\/peds.103.3.e28","article-title":"Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America","volume":"103","author":"Levine","year":"1999","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T22:33:24Z","timestamp":1585953204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04007315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":37,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0264410X04007315"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.08.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}